EMAIL DETAILS

One item we skipped over on IPS today is how we frame charging for the
first trials with 3rd (perspectively Point and Highlands). Let’s make sure
we have an approach with the funds and assume a $25k - $50k range per? I
think we need to mention it in our very next conversation before we get too
far down the line.


On Tue, Jun 1, 2010 at 6:05 PM, Chris Heinz <cheinz@rosemontcapital.com>wrote:

> link
> http://www.ted.com/talks/blaise_aguera_y_arcas_demos_photosynth.html
>
>
> Christopher Heinz
> Rosemont Capital, LLC
>
>
> ------------------------------
> *From:* Chris Heinz
> *Sent:* Tue 6/1/2010 2:44 PM
> *To:* ncallahan@rosemontseneca.com; darcher@rosemontseneca.com; 'Eric
> Schwerin'; 'Hunter Biden'
> *Subject:* RE: RSP Management Status
>
> Guys,
> Here is a preso from Ted on a Microsoft owned technology. I think
> it's analagous to IPS, but in the visual medium, not text based. What do you
> guys think?
>
> Might be worth sending to Thad.
>
> Christopher Heinz
> Rosemont Capital, LLC
>
>
> ------------------------------
> *From:* Neil Callahan [mailto:ncallahan@rosemontseneca.com]
> *Sent:* Tue 6/1/2010 12:00 PM
> *To:* darcher@rosemontseneca.com; 'Eric Schwerin'; 'Hunter Biden';
> amperson@rosemontseneca.com; Chris Heinz
> *Subject:* RSP Management Status
>
> Documents for today’s call.
>
>
>
>
> ------------------------------------------------------------------------------------------
>
> Neil Callahan
>
> Rosemont Seneca
>
> 401 Greenwich Street, Suite 400 | New York NY 10013 | 212-933-9965
>
> 1010 Wisconsin Avenue, Suite 705 | Washington DC 20007 | 202-333-1880
>
> 917-945-9516 (mobile)
>
> 866-749-8879 (fax)
>
>